News | EP Lab | May 21, 2018

Radiofrequency Transseptal Needle Associated With 40 Percent Decrease in Silent Cerebral Embolism

A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.

May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40 percent lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients.[1] 

The study publication follows a consensus statement recently revised by Heart Rhythm Society and other international societies which suggests that, though the long-term impact of silent cerebral embolism needs investigation, physicians should take the necessary measures to avoid it.[2] These are the first study results to find that a lower incidence could be associated with the type of transseptal needle chosen for ablation procedures.

The study compared the post-procedural MRI scans of 232 patients where AF ablation was done using either the NRG needle or a mechanical needle. Authors suggest there were two differences between the procedures that may contribute to lower risk of silent cerebral embolism.

Advancing the sharp tip of a mechanical needle through a plastic sheath and dilator can create shaved-off plastic particles, which, if entering the bloodstream, may result in embolic material being transferred into the patient's body. The blunt-tipped RF needle does not produce this skiving effect.

In addition, the study showed a 14-minute shorter mean procedure time when using the RF needle, which, as per the authors, could contribute to the lower incidence of silent cerebral embolism. The study authors also suggest the shorter procedure time could lead to cost efficiencies for electrophysiology labs.

"These study findings join the large body of evidence which confirms that using the NRG needle will result in a more predictable procedure and outcome for physicians," said Gareth Davies, Ph.D., research and development manager at Baylis Medical. "This is part of our larger focus on continually identifying the challenges faced by physicians in order to develop innovative solutions to meet the needs of their patients."

The research findings were published in April 2018.

For more information:


1. Tokuda et al. Radiofrequency Needle for Transseptal Puncture is associated with Lower Incidence of Thromboembolism during Catheter Ablation of Atrial Fibrillation: Propensity score-matched analysis. Heart and Vessels. 10 April 2018. [Epub ahead of print]

2. Calkins et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275-e444.

Related Content

The Acutus Medical AcQBlate Force sensing ablation catheter.

The Acutus Medical AcQBlate Force sensing ablation catheter.

News | Ablation Systems | April 05, 2021
April 5, 2021 — Acutus Medical today announced initial U.S.
The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News | Ablation Systems | May 08, 2020
May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SER
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20

The Affera Inc. pulsed field (PF) energy radiofrequency ablation system.

Feature | Ablation Systems | May 08, 2020
May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or par
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...